ICD-10-CM Billable Code

A50.3

Late congenital syphilitic oculopathy

Clinical Classification Guidelines

Excludes Type 1

  • Hutchinson's triad (A50.53)

Medical Intelligence & Overview

Late congenital syphilitic oculopathy is a condition that affects the eyes of individuals born with syphilis, a bacterial infection caused by Treponema pallidum. This condition typically develops later in life, often years after the initial infection, leading to various eye problems. Recognizing and understanding this condition can help in managing its effects and preventing potential vision loss.

Causes & Symptoms

Clinical Causes: Transmission of Treponema pallidum from mother to child during pregnancy, leading to congenital syphilis Progression of untreated or inadequately treated congenital syphilis over time Bacteria continuing to affect eye tissues, causing inflammation and damage in later years

Key Symptoms: Gradual loss of vision Eye pain or discomfort Sensitivity to light (photophobia) Redness and swelling of the eye Changes in the appearance of the eye, such as scarring or lesions Potential development of cataracts or other structural eye abnormalities Presence of a hazy or blurred vision Possible untreated or unnoticed initial eye symptoms, with problems emerging later

Diagnostic & Treatment

Diagnosis Path: Diagnosing late congenital syphilitic oculopathy involves a comprehensive eye examination by an ophthalmologist, including visual acuity tests and detailed inspection of eye structures. Laboratory tests to detect syphilis, such as blood tests (e.g., VDRL, RPR) and cerebrospinal fluid analysis, are crucial for confirming infection. A history of congenital syphilis or related symptoms in early childhood may also support the diagnosis.

Treatment Protocols: Treatment generally involves the administration of antibiotics, primarily penicillin, to eradicate the bacterial infection. The specific regimen depends on the severity and extent of eye involvement. Additional supportive treatments such as corticosteroids may be used to reduce inflammation. Regular follow-up is essential to monitor the effectiveness of therapy and to address any ongoing or residual issues in eye health.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is A50.3 a billable ICD-10 code?
Yes, A50.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report A50.3?
Clinical documentation must specify the nature of Late congenital syphilitic oculopathy and any associated comorbidities for accurate reporting.

Cite this Clinical Reference